ENTER


Полный размерЗакрыть
Полный размерЗакрыть
Полный размерЗакрыть
Полный размерЗакрыть

Our experience using of plication for treatment of strabismus

Details
Details
Published: Thursday, 10 December 2015 22:42
Written by Super User
Hits: 1456

Serdiuk V. N.1, Klopotska N. H.2, Tarnopolska I. N.1, Petrenko Ye. A.1, Tykhomyrova V. V.1

1Dnipropetrovsk Regional Clinical Eye Hospital of Dnipropetrovsk Regional Council, Dnipropetrovsk, Ukraine

2Dnipropetrovsk Medical Academy, Dnipropetrovsk, Ukraine

Summary. Plication is a way to strengthen the muscle in strabismus by creating muscular folds of the middle third of the muscle. Aim is to investigate the plication effectiveness in different types of strabismus in children. Plication was performed in 19 children with concomitant strabismus, 3 with traumatic and 1 with paralytic strabismus due to n. abducens lesion. Plication was performed as a separate operation (in case of second surgical treatment) or in combination with the recession of antagonist muscle. In 3–4 days after surgery complete elimination of the angle of strabismus was observed in 19 children (82.6 %). A year later recurrence of strabismus was observed in 3 patients. Binocular vision was recovered in 13 patients (59.1 %). The worst results were observed in cases of paralytic strabismus and concomitant strabismus with large angles of deviation and low visual functions. Plication is easily doable effective operation for treatment of strabismus in children.

Keywords: children, strabismus, surgery, plication.

 

Efficacy, tolerability and safety of tafluprost ophthalmic solution in glaucoma

Details
Details
Published: Thursday, 10 December 2015 07:21
Written by Super User
Hits: 1544

Havryliuk T.I.1, Danovska V.M.2, Yanenko V.O.3

1Cherkasy Regional Hospital, Cherkasy, Ukraine

2Second Cherkasy Clinic, Cherkasy, Ukraine

3Rigional Territorial Medical Association, Gorodishche, Ukraine

Summary. This article provides information about the efficacy, tolerability and safety of eye drops 0.0015 % tafluprost (Taflotan®, Santen, Finland) for the treatment of patients with glaucoma. Control of intraocular pressure (IOP) during the study was carried out at baseline and at 4–6 and 12 weeks after the start of application of eye drops Taflotan®. Also was еvаluаted the tolerability and safety of the drug. In primary open angle glaucoma after 12 weeks of monotherapy with tafluprost or combined treatment with tafluprost and beta-blockers showed a significant decrease in IOP. When pseudoexfoliative and pigmentary glaucoma, a significant reduction in IOP was recorded as in tafluprost monotherapy and combined treatment. In objective assessment of the impact of the drug on the surface of the eye Taflotan® shown that the prescription of tafluprost preservative-free not registered conjunctival hyperemia and the lack of negative influence in any of the surveyed patients.

It was found that the application of eye drops without preservative products Taflotan® tears and tear film stability remained normal throughout the period of treatment and observation. In the group of patients treated with Taflotan® preservative in the vial with a slight decrease tear secretion, tear film stability which were compensated with the additional purpose lubricants. Most patients rated tolerance of eye drops Taflotan® as «excellent» and «good».

Keywords: glaucoma, intraocular pressure, tafluprost, portability, security applications.

More Articles ...

  1. Character binocular field of vision and quality of life in patients with primary open-angle glaucoma
  2. Riboflavin-UVA corneal collagen cross-linking (CXL) and flat fitting RGP lens in progressive keratoconus

Page 2 of 5